COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
투석에서의 코로나19: 임상적 영향, 면역 반응, 예방 및 치료
Review
[키워드] absence
adenoviral vector vaccine
adverse effect
antibody
antibody levels
BNT162b2
BNT162b2 vaccine
booster dose
candidate
Candidates
Care
clinical impact
Course
COVID-19
COVID-19 pandemic
develop
dialysis
disease severity
dose
Evidence
Hemodialysis
Hospitalization
humoral immune response
immune
Immune escape
immune response
immune responses
Immunity
immunogenicity
increase
increased risk
Infection
initial
long-lasting
monoclonal antibody
Mortality
mRNA
mRNA vaccines
mRNA-1273
mRNA-1273 vaccine
neutralizing monoclonal antibodies
Patient
Preliminary data
prolonged viral shedding
Prophylaxis
PROTECT
Psychological distress
Reinfection
responses
reveal
robust
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccination
SARS-CoV-2 variant
SARS-CoV-2 variants
severe disease
significantly
survivor
Therapeutic strategies
therapeutic strategy
Treatment
vaccination
vaccine response
Viral
viral shedding
virtue
[DOI] 10.1016/j.kint.2022.01.022 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.kint.2022.01.022 PMC 바로가기 [Article Type] Review